Darren Barrington-Light, senior manager product marketing for Thermo Fisher Scientific, explains the importance of integrating LIMS into the pharmaceutical data chain
Data governance is an integral part of a regulated company’s quality system. Having a chromatography data system can simplify system administration and ensure regulatory compliance (including 21 CFR Part 11) and adherence to data integrity guidelines.
Thermo Fisher Scientific has announced that it has acquired informatics software provider Core Informatics - a company that specialises cloud-based software to support scientific data management
The new ChemSearch mobile app features the intuitive mobile chemical drawing technology, ChemDoodle from iChemLabs, designed to enable scientists to easily draw and search chemical structures to identify the right chemicals and compounds required for their work
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
